Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17933528rdf:typepubmed:Citationlld:pubmed
pubmed-article:17933528lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:17933528lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:17933528lifeskim:mentionsumls-concept:C0668289lld:lifeskim
pubmed-article:17933528lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:17933528lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:17933528lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:17933528lifeskim:mentionsumls-concept:C0072780lld:lifeskim
pubmed-article:17933528lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:17933528pubmed:issue23lld:pubmed
pubmed-article:17933528pubmed:dateCreated2007-11-6lld:pubmed
pubmed-article:17933528pubmed:abstractTextA series of trans-4-phenylpyrrolidine-3-carboxamides were synthesized and characterized as potent ligands of the human melanocortin-4 receptor. Interestingly, a pair of diastereoisomers 20f-1 and 20f-2 displayed potent functional agonist and antagonist activity, respectively. Thus, the 3S,4R-compound 20f-1 possessed a K(i) of 11nM and an EC(50) of 24nM, while its 3R,4S-isomer 20f-2 exhibited a K(i) of 8.6 and an IC(50) of 65nM. Both compounds were highly selective over other melanocortin receptor subtypes. The MC4R agonist 20f-1 also demonstrated efficacy in diet-induced obese rats.lld:pubmed
pubmed-article:17933528pubmed:languageenglld:pubmed
pubmed-article:17933528pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17933528pubmed:citationSubsetIMlld:pubmed
pubmed-article:17933528pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17933528pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17933528pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17933528pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17933528pubmed:statusMEDLINElld:pubmed
pubmed-article:17933528pubmed:monthDeclld:pubmed
pubmed-article:17933528pubmed:issn1464-3405lld:pubmed
pubmed-article:17933528pubmed:authorpubmed-author:XXXlld:pubmed
pubmed-article:17933528pubmed:authorpubmed-author:TucciFabio...lld:pubmed
pubmed-article:17933528pubmed:authorpubmed-author:MarinkovicDra...lld:pubmed
pubmed-article:17933528pubmed:authorpubmed-author:FosterAlan...lld:pubmed
pubmed-article:17933528pubmed:authorpubmed-author:JiangWanlongWlld:pubmed
pubmed-article:17933528pubmed:authorpubmed-author:MarkisonStacy...lld:pubmed
pubmed-article:17933528pubmed:authorpubmed-author:FleckBeth ABAlld:pubmed
pubmed-article:17933528pubmed:authorpubmed-author:ArellanoMelis...lld:pubmed
pubmed-article:17933528pubmed:authorpubmed-author:ChenCaroline...lld:pubmed
pubmed-article:17933528pubmed:authorpubmed-author:WenJennyJlld:pubmed
pubmed-article:17933528pubmed:authorpubmed-author:TranJoe AJAlld:pubmed
pubmed-article:17933528pubmed:authorpubmed-author:HoareSam RSRlld:pubmed
pubmed-article:17933528pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17933528pubmed:day1lld:pubmed
pubmed-article:17933528pubmed:volume17lld:pubmed
pubmed-article:17933528pubmed:ownerNLMlld:pubmed
pubmed-article:17933528pubmed:authorsCompleteYlld:pubmed
pubmed-article:17933528pubmed:pagination6546-52lld:pubmed
pubmed-article:17933528pubmed:meshHeadingpubmed-meshheading:17933528...lld:pubmed
pubmed-article:17933528pubmed:meshHeadingpubmed-meshheading:17933528...lld:pubmed
pubmed-article:17933528pubmed:meshHeadingpubmed-meshheading:17933528...lld:pubmed
pubmed-article:17933528pubmed:meshHeadingpubmed-meshheading:17933528...lld:pubmed
pubmed-article:17933528pubmed:meshHeadingpubmed-meshheading:17933528...lld:pubmed
pubmed-article:17933528pubmed:meshHeadingpubmed-meshheading:17933528...lld:pubmed
pubmed-article:17933528pubmed:meshHeadingpubmed-meshheading:17933528...lld:pubmed
pubmed-article:17933528pubmed:meshHeadingpubmed-meshheading:17933528...lld:pubmed
pubmed-article:17933528pubmed:meshHeadingpubmed-meshheading:17933528...lld:pubmed
pubmed-article:17933528pubmed:year2007lld:pubmed
pubmed-article:17933528pubmed:articleTitleSynthesis and characterization of pyrrolidine derivatives as potent agonists of the human melanocortin-4 receptor.lld:pubmed
pubmed-article:17933528pubmed:affiliationDepartment of Medicinal Chemistry, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, CA 92130, USA.lld:pubmed
pubmed-article:17933528pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17933528pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:17933528lld:chembl